ESPE Abstracts (2016) 86 P-P1-817

ESPE2016 Poster Presentations Syndromes: Mechanisms and Management P1 (36 abstracts)

Silver-Russell Syndrome with 11p15 Epimutation: Clinical Analysis of Adrenarche, Central Puberty and Body Mass Index in a Cohort of French Children

Ana Canton , Frédéric Brioude & Irène Netchine


INSERM UMR S 938, UPMC, Armand Trousseau Hospital, Pediatric Endocrinology, Paris, Ile de France, France


Background: Silver-Russell syndrome (SRS) is characterized by intrauterine and postnatal growth retardation, a typical phenotype and feeding difficulties. It is related to 11p15 ICR1 hypomethylation in up to 50% of the cases. Some patients may exhibit signs of early puberty or premature adrenarche, including premature pubarche and/or an exaggerated adrenarche (high dehidroepyandrosterone sulfate (DHEAS) levels for chronological age). Despite early feeding difficulties, some children develop a rapid weight catch-up, probably when overfed, resulting in a marked BMI gain.

Objective: To analyse the clinical features of a group of 11p15 SRS children, regarding signs of adrenarche, signs of central puberty and anthropometric data.

Method: We analysed 16 patients 10 years or older followed at the same paediatric endocrinology unit, collecting retrospectively the following data: anthropometric data, age of pubarche, age of thelarche or testicular enlargement, DHEAS levels and baseline insulin-like growth factor 1(IGF-1) levels (without growth hormone (GH)).

Results: From the 16 patients analysed, 6 (37%; 5 boys and 1 girl) had premature pubarche, and 9 (56%; 6 boys and 3 girls) had exaggerated adrenarche. One girl presented with precocious puberty. Thirteen (81%) presented first with adrenarche signs. Baseline IGF-1 levels were ≥ 2.0 SD in 7 (44%), and between 0 and 2.0 SD in 6 (37%). All patients (100%) had a marked BMI increase 1 to 2 years before puberty and/or adrenarche onset (BMI increase of at least +1.0 SD). Final height was available for 6: 3 did not catch-up to a height > −2.0 SD and 2 did not catch-up to their target heights, regardless of GH treatment.

Conclusion: Premature and/or exaggerated adrenarche seems to be common among these patients, regardless of gender. A rapid increase in BMI may lead to premature adrenarche and early puberty, compromising thereby the final height despite GH treatment.

Volume 86

55th Annual ESPE (ESPE 2016)

Paris, France
10 Sep 2016 - 12 Sep 2016

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.